Dyne therapeutics market cap
WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … WebComplete Dyne Therapeutics Inc. stock information by Barron's. View real-time DYN stock price and news, along with industry-best analysis. ... Market Cap. Vertex Pharmaceuticals Inc.-1.62 % $76 ...
Dyne therapeutics market cap
Did you know?
WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. ... The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day … WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ...
WebMar 24, 2024 · Dyne Therapeutics Inc Registered Shs's market capitalization is $642.40 M by 56.34 M shares outstanding. Dyne Therapeutics Stock Snapshot 11.04 WebOur data points out that Dyne Therapeutics, Inc. (DYN) is ranked #5407 out of 13000 companies on February - 2024. DYN's Market Capitalization is $700 million and the …
WebDYN (Dyne Therapeutics) Market Cap as of today (January 08, 2024) is $606.76 Mil. Market Cap explanation, calculation, historical data and more DYN (Dyne … WebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios.
WebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's stock …
WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ... soil fertility in hindiWebMar 23, 2024 · DYN Complete Dyne Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Market Cap $646.76M; Shares Outstanding … soil fertility research instituteWebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else.. slsy adult mountain tricycle 7 speedWebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. soil field testWebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious … soil field density testWebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … soil field test methodWebApr 11, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven … soil fertility world map